Press Releases

Elligo and Avallano Launching Patient-First, AI-Powered Clinical Trials Ecosystem

Elligo Health Research®, the largest healthcare-enabling research organization, today announced a partnership with Avallano, a data privacy and healthcare technology company, to launch myTrialsConnectSM, a scalable research community powered by artificial intelligence (AI), that was built to serve patients, providers, sites, and the biopharma industry.

Elemental, Ions and Water (Karl Fischer) Standards Make Analytical Testing More Accurate and Easier

Samsung Biologics reports third quarter 2023 financial results

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the third quarter of fiscal year 2023.

Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach

Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox

Profacgen Updated Its Electrophoretic Mobility Shift Assay (EMSA) Service

Creative BioMart Provides a Wide Range of Biomarker Proteins for Research Use

Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

CD BioGlyco Releases One-Stop Services for Glycoprotein-Based Vaccine Development

Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies

Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry

Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.

Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology

Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services

Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases

Andelyn Biosciences, a gene therapy CDMO, has joined forces with Purespring Therapeutics to accelerate the development of gene therapies for chronic kidney diseases. Purespring is known for its innovative treatments that can slow or halt these diseases. The partnership leverages Andelyn's AAV production expertise and suspension platform under GMP to expedite the clinical advancement of Purespring's therapies. Both organizations share a commitment to improving human health through gene therapies. This collaboration will benefit from Andelyn's advanced GMP manufacturing capabilities in Columbus, Ohio, and is poised to offer hope to patients with kidney diseases.

Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront

BOC Sciences at TIDES Europe 2023: Key Chemicals and XDC Platform to Be Exhibited

BOC Sciences will attend "TIDES Europe: Oligonucleotide & Peptide Therapeutics", delivered as a hybrid event from 30 Oct - 1 Nov 2023, in Amsterdam, NL. Its high-yield nucleosides & nucleotides, as well as a newly launched XDC platform, will be exhibited in front of the industry.

Cresset Targets International Growth with Innovate UK Scaleup Programme

Drug discovery specialists Cresset has joined Innovate UK’s Scaleup Programme for businesses with high growth potential

CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules

CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights

CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology